Suven Life Sciences Limited Patent applications |
Patent application number | Title | Published |
20140187581 | HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS - The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. | 07-03-2014 |
20140148440 | HETEROCYCLYL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS - The present invention relates to heterocyclyl compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to Histamine H | 05-29-2014 |
20140135304 | NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS - The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. | 05-15-2014 |
20130085145 | IMATINIB MESILATE PHARMACEUTICAL TABLET - The present invention provides a pharmaceutical tablet, comprising Imatinib in an amount of 50-75% w/w of the total tablet weight and comprising at least one pharmaceutically acceptable excipient without a binding agent and the process for preparation of the same. | 04-04-2013 |
20130005709 | SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS - The present invention relates to novel sulfone compounds as 5-HT | 01-03-2013 |
20120322808 | Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS - The present invention relates to novel α | 12-20-2012 |
20120315657 | FUNCTIONAL ASSAY FOR 5-HT2A, HISTAMINE H1 OR ADRENERGIC ALPHA 1B RECEPTORS - The present invention provides novel functional assay for 5-HT | 12-13-2012 |
20120277216 | 1,2-DIHYDRO-2-OXOQUINOLINE COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS - The present invention relates to novel 1,2-dihydro-2-oxoquinoline compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. | 11-01-2012 |
20120129816 | ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel aryl sulfonamide amine compounds of the formula (I), their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates described herein and pharmaceutically acceptable compositions containing them. | 05-24-2012 |
20110281849 | Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands - The present invention relates to novel aryl indolyl sulfonamide compounds of the formula (I), their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates described herein and pharmaceutically acceptable compositions containing them. | 11-17-2011 |
20100222597 | Process for the preparation of losartan - The invention relates to a improved process for the preparation of Losartan and its potassium salt, which comprises: (i) reacting bromo OTBN with BCFI in the presence of a base and a phase transfer catalyst to produce a cyano aldehyde; reacting the formed cyano aldehyde with sodium azide in the presence of tributyl tin chloride to produce aldehyde tetrazole; reducing the formed aldehyde tetrazole with sodium borohydride to produce Losartan; and, if desired, converting the formed Losartan to its potassium salt by known method. | 09-02-2010 |
20100216861 | AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel amino arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them: The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The compounds of the invention are useful in the treatment of various disorders that are related to 5-HT | 08-26-2010 |
20100204501 | PROCESS FOR THE PREPARATION OF MALATHION AND ITS INTERMEDIATE - The present invention relates to the improved process for the preparation of highly pure form of S-[1,2-(dicarbethoxy)-ethyl]O,O-dimethyl phosphorodithioate having formula (I). The compound of formula (I) has adopted name “Malathion”. The present invention also relates to the novel process of preparing intermediate O,O-dimethyldithiophosphoric acid of formula (II), which is useful in the preparation of Malathion. The Malathion prepared by the process of this invention is highly storage stable and toxic impurities are much lower than any other commercial preparation available for the pharmaceutical purpose. | 08-12-2010 |
20100087484 | AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel aminoalkoxy arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HT | 04-08-2010 |
20090131507 | N-arylsulfonyl-3-aminoalkoxyindoles - N-arylsulfonyl-3-aminoalkoxyindoles indole compounds, radioisotopes, stereoisomers, geometric forms, N-oxides, polymorphs and pharmaceutically acceptable salts. | 05-21-2009 |